Coronary and Structural Interventions Ulm - Transcatheter Mitral Valve Repair (CSI-Ulm-TMVR)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03104660

Enrollment

355

Registered

2017-04-07

Start date

2017-03-15

Completion date

2018-12-31

Last updated

2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Valve Regurgitation

Brief summary

To evaluate the long-term results after transcatheter mitral valve repair

Detailed description

Patients with transcatheter mitral valve repair are followed for 10 years to demonstrate efficacy and safety.

Interventions

DEVICECE certified mitral valve repair systems

Patients receive a transcatheter mitral valve repair with CE certified transcatheter mitral repair systems.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

CE certified mitral valve repair systems

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* mitral valve regurgitation * transcatheter mitral valve repair

Exclusion criteria

* no written informed consent

Design outcomes

Primary

Measure	Time frame	Description
Major adverse cerebral and cardiac events	10 years	Major adverse cerebral and cardiac events

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026